Post-COVID syndrome or persistent COVID and depression

Introduction Since the start of COVID19 pandemic, numerous patients have exhibited symptoms related to viral infection once acute phase has resolved. The most frequent are fatigue or weakness, cognitive difficulties, insomnia, and anxiety depression. It been observed that persistence these is more common in cases severe infections. Objectives We expose a case exemplifies it; A 60-year-old man suffering from during 2021, with bilateral pneumonia secondary pneumothorax. Three months after episode, he continues present symptoms, such as dyspnea, asthenia, arthromyalgia, nausea, hyporexia, memory lapses, depressive mood apathy, anhedonia suicidal ideas. Methods patient starts follow-up Mental Health antidepressant treatment Vortioxetine 10mg. In following presented significant improvement consisting decrease arthromyalgia especially anxious mood, disappearing ideation. However, failures draws attention, which remain similar degree slight subjective improvement. exploration complementary test were following: - Chest CT: Hydropneumothorax, parenchymal infiltrates, alveolar consolidations, left lamellar Head CT, complete analysis, microbiological cytological studies without relevant resolution. Assessment by Rehabilitation Neurology service. Results This exposes existence post-COVID syndrome, where persist, including anxious-depressive moderate-severe intensity. different diagnoses considered Post-COVID Adjustment disorder mixed symptomatology, Depressive episode. Conclusions consider this others similar, increasingly routine clinical practice, etiopathogenesis syndrome interest. found it difficult discern origin not being able differentiate an adaptive difficulty situation (added COVID pandemic context), versus organic affectation improves when receiving pharmacological treatment, antidepressants. Disclosure Interest None Declared